Global menu

Our global pages


Helping life sciences industry provider bring patient-centric solutions

  • United Kingdom
  • Global


    Eversheds Sutherland advises management team on sale of CRF Health

    Eversheds Sutherland has advised the management team of CRF Health (CRF) – a global provider of electronic clinical outcome assessments (eCOAs) and eConsent solutions for the life sciences industry – on its sale to Genstar Capital, a leading investor in healthcare technology and services companies.

    Headquartered in Finland, CRF has been majority-owned by Vitruvian Partners, a leading growth-and technology-focused investment firm, since 2015.

    As part of the transaction, CRF will be combined with Bracket, a provider of software and technology-enabled solutions utilised in clinical trials. Bracket is a portfolio company of Genstar.

    The newly combined organisation will drive accelerated value for pharmaceutical companies and CRO customers, providing patient-centric solutions, combined with deep and broad therapeutic area expertise, across a strong and efficient global footprint.

    The Eversheds Sutherland team was led by Richard Moulton, Partner and Head of Corporate (International), and comprised Senior Associate Alex McCarney, Senior Associate James Bridges, Legal Director Wyn Jones and Associate Hannah Kaye.

    Richard Moulton commented:

    “This is a significant and exciting deal for CRF Health and one that we are very pleased to have supported on.”

    Joel Hanson, General Counsel, CRF Health, commented:

    “We thoroughly enjoyed working with Richard and the Eversheds Sutherland team. Their commercial advice was rooted in a good understanding of our objectives, and their legal expertise and pragmatic approach proved invaluable to the success of the deal.”

    The transaction is expected to be completed by the end of 2018.

    This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

    < Go back